1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2024
-
Mark
Cohort profile : the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)—acute coronary syndrome and percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
(
- Contribution to journal › Article
-
Mark
Incidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicentre observational study (AMESI Study)
(
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
(
- Contribution to journal › Article
-
Mark
Low-grade inflammation in persons with recently diagnosed type 2 diabetes : The role of abdominal adiposity and putative mediators
(
- Contribution to journal › Article
-
Mark
Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population
(
- Contribution to journal › Article
- 2023
-
Mark
Tumour Growth Models of Breast Cancer for Evaluating Early Detection—A Summary and a Simulation Study
(
- Contribution to journal › Article
-
Mark
Burden of disease and management of osteoarthritis and chronic low back pain : Healthcare utilization and sick leave in Sweden, Norway, Finland and Denmark (BISCUITS): Study design and patient characteristics of a real world data study
(
- Contribution to journal › Article